ClinicalTrials.gg
RecruitingNCT06522347Updated Jul 26, 2024

Mycobacteria Registry Study: Prospective Observational Study in Austria

An observational study in Non-Tuberculous Mycobacterial Pneumonia and Tuberculosis, sponsored by Ludwig Boltzmann Institute for Lung Health. Recruiting at 3 sites in Austria. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-07-26.

Sponsored by Ludwig Boltzmann Institute for Lung Health · Observational

From the registry’s dates

  • Started Jan 2023; still recruiting 3 years 9 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
1,000
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this non-interventional registry study is to systematically collect epidemiological and clinical data throughout the treatment course to learn about effectiveness of treatments. We will document the natural course of therapy without additional interventions. The main question to answer is:

What are the risk factors for mortality due to infection with Mycobacteria tuberculosis (TB) or Nontuberculous mycobacteria (NTM) in Austria?

Data from participants already receiving treatment as part of their regular medical care for TB or NTM infections will be collected.

02

Conditions studied

  • Non-Tuberculous Mycobacterial Pneumonia
  • Tuberculosis

Keywords

  • Mycobacterium tuberculosis
  • Nontuberculous Mycobacteria
  • Mycobacterium Infections
03

In context

Tuberculosis

1,435 studies on the registry are indexed under Tuberculosis; 208 are open to participants now.

This study's planned enrollment of 1,000 is above the median of 240 across 427 observational studies indexed under Tuberculosis.

Browse Tuberculosis studies →

Lead sponsor

Ludwig Boltzmann Institute for Lung Health is the lead sponsor of 4 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Any patient presenting to outpatient clinic or ward of Klink Penzing or Klinik Hietzing due to Mycobacteria infection.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • patients diagnosed with Mycobacterium tuberculosis or non-tuberculous mycobacteria infection
  • individuals aged 18 years or older
  • written informed consent

Exclusion criteria

Exclusion Criteria:

  • to not comprehend and rightfully judge participation
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
1,000 participants (estimated)
Target follow-up
12 Months
Patient registry
Yes
06

What researchers measure

Primary outcomes

  1. Mortality

    Mortality due to tuberculosis or NTM infection in Austria

    Time frame: 30 years

Secondary outcomes

  1. Prevalence

    Prevalence of mycobacterial infections in Austria

    Time frame: 30 years

  2. Patient cohort

    Description of the patient cohort

    Time frame: 30 years

  3. Risk factors

    Identification of risk factors for treatment failure and complications

    Time frame: 30 years

07

Study locations

3 of 3 sites recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 26, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06522347
Lead sponsor
Ludwig Boltzmann Institute for Lung Health
Collaborators
Sigmund Freud PrivatUniversitat
Responsible party
Robab Breyer-Kohansal (Prim.a Priv.-Doz.in Dr.in, Ludwig Boltzmann Institute for Lung Health) — Principal investigator
First posted
Jul 26, 2024
Start date
Jan 1, 2023
Primary completion
Dec 31, 2053 (estimated)
Completion
Dec 31, 2053 (estimated)
Last update
Jul 26, 2024

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion